Advisor Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1.5M | Buy |
13,857
+2,532
| +22% | +$274K | 0.01% | 964 |
|
|
2019
Q3 | $1.11M | Buy |
11,325
+626
| +6% | +$61.2K | 0.01% | 1082 |
|
|
2019
Q2 | $1.4M | Buy |
10,699
+1,619
| +18% | +$212K | 0.01% | 930 |
|
|
2019
Q1 | $1.23M | Buy |
9,080
+1,881
| +26% | +$254K | 0.01% | 970 |
|
|
2018
Q4 | $701K | Sell |
7,199
-118
| -2% | -$11.5K | 0.01% | 1176 |
|
|
2018
Q3 | $1.02M | Buy |
7,317
+1,901
| +35% | +$264K | 0.01% | 965 |
|
|
2018
Q2 | $672K | Buy |
5,416
+202
| +4% | +$25.1K | 0.01% | 1117 |
|
|
2018
Q1 | $581K | Sell |
5,214
-216
| -4% | -$24.1K | 0.01% | 1212 |
|
|
2017
Q4 | $649K | Buy |
5,430
+906
| +20% | +$108K | 0.01% | 1159 |
|
|
2017
Q3 | $635K | Buy |
4,524
+288
| +7% | +$40.4K | 0.01% | 1059 |
|
|
2017
Q2 | $515K | Buy |
4,236
+860
| +25% | +$105K | 0.01% | 1126 |
|
|
2017
Q1 | $409K | Buy |
3,376
+430
| +15% | +$52.1K | 0.01% | 1194 |
|
|
2016
Q4 | $361K | Sell |
2,946
-667
| -18% | -$81.7K | 0.01% | 1195 |
|
|
2016
Q3 | $442K | Buy |
3,613
+200
| +6% | +$24.5K | 0.01% | 1035 |
|
|
2016
Q2 | $396K | Buy |
+3,413
| New | +$396K | 0.01% | 1040 |
|